Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel

por Amer, Eglal I., Abou-El-Naga, Iman F., Boulos, Laila M., Ramadan, Heba S., Younis, Salwa S.
Publicado 2022

Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection

por Said, Doaa E., Amer, Eglal I., Sheta, Eman, Makled, Shaimaa, Diab, Hala E., Arafa, Fadwa M.
Publicado 2022

Nano-Encapsulated Antioxidant: Retinoic Acid as a Natural Mucosal Adjuvant for Intranasal Immunization against Chronic Experimental Toxoplasmosis

por Said, Doaa E., Amer, Eglal I., Sheta, Eman, Makled, Shaimaa, Arafa, Fadwa M., Diab, Hala E.
Publicado 2023

Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model

por Mossallam, Shereen F, Amer, Eglal I, Ewaisha, Radwa E, Khalil, Amal M, Aboushleib, Hamida M, Bahey-El-Din, Mohammed
Publicado 2015

Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study

por Eissa, Maha M., El-Moslemany, Riham M., Ramadan, Alyaa A., Amer, Eglal I., El-Azzouni, Mervat Z., El-Khordagui, Labiba K.
Publicado 2015

Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens

por El-Faham, Marwa H., Eissa, Maha M., Igetei, Joseph E., Amer, Eglal I., Liddell, Susan, El-Azzouni, Mervat Z., Doenhoff, Michael J.
Publicado 2017

Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?

por Amer, Eglal I., Allam, Sonia R., Hassan, Aceel Y., El-Fakharany, Esmail M., Agwa, Mona M., Khattab, Sherine N., Sheta, Eman, El-Faham, Marwa H.
Publicado 2023